BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$478M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Alibaba
BABA
|
+$295M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$995M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$112M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$109M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.51% |
| 2 | Financials | 5.78% |
| 3 | Consumer Discretionary | 5.73% |
| 4 | Healthcare | 5.19% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCCY
3726
DELISTED
1st Constitution Bancorp
FCCY
| $22.3K | ﹤0.01% |
1,205
-375
| -24% | -$6.99K |
|
|
PVTL
3727
DELISTED
Pivotal Software, Inc.
PVTL
| $22.2K | ﹤0.01% |
2,104
+519
| +33% | +$9.21K |
|
3728
Peoples Bancorp of North Carolina
PEBK
$235M
| $22.2K | ﹤0.01% |
739
-244
| -25% | -$6.74K |
|
|
DCPH
3729
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $22.2K | ﹤0.01% |
984
-850
| -46% | -$19.9K |
|
3730
IES Holdings
IESC
$15.5B
| $22.1K | ﹤0.01% |
1,175
-594
| -34% | -$10.8K |
|
|
FNHC
3731
DELISTED
FedNat Holding Company Common Stock
FNHC
| $22.1K | ﹤0.01% |
1,551
-855
| -36% | -$13K |
|
|
MRNS
3732
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $21.9K | ﹤0.01% |
1,319
-1,193
| -47% | -$20.7K |
|
|
ATHX
3733
DELISTED
Athersys, Inc. Common Stock
ATHX
| $21.9K | ﹤0.01% |
521
-454
| -47% | -$18.6K |
|
3734
Mid Penn Bancorp
MPB
$958M
| $21.8K | ﹤0.01% |
874
-122
| -12% | -$3.01K |
|
|
FLNT
3735
Fluent
FLNT
$130M
| $21.7K | ﹤0.01% |
673
-461
| -41% | -$16.2K |
|
3736
Oak Valley Bancorp
OVLY
$281M
| $21.6K | ﹤0.01% |
1,105
-362
| -25% | -$6.94K |
|
3737
MannKind Corp
MNKD
$1.23B
| $21.6K | ﹤0.01% |
18,764
-15,732
| -46% | -$21.8K |
|
3738
Carter Bankshares
CARE
$709M
| $21.6K | ﹤0.01% |
+1,092
| New | +$21.3K |
|
3739
OP Bancorp
OPBK
$234M
| $21.5K | ﹤0.01% |
1,987
-639
| -24% | -$6.19K |
|
3740
Sibanye-Stillwater
SBSW
$7.51B
| $21.4K | ﹤0.01% |
4,507
-619
| -12% | -$2.45K |
|
3741
Universal Logistics Holdings
ULH
$503M
| $21.4K | ﹤0.01% |
951
-779
| -45% | -$16.6K |
|
|
LEVL
3742
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $21K | ﹤0.01% |
841
-284
| -25% | -$6.82K |
|
3743
Pure Cycle
PCYO
$275M
| $21K | ﹤0.01% |
1,978
-1,647
| -45% | -$16.5K |
|
3744
Ascent Industries
ACNT
$138M
| $21K | ﹤0.01% |
1,342
-419
| -24% | -$7.22K |
|
3745
Arvinas
ARVN
$588M
| $21K | ﹤0.01% |
953
-664
| -41% | -$14K |
|
|
NAGE
3746
Niagen Bioscience
NAGE
$244M
| $20.9K | ﹤0.01% |
4,495
-3,647
| -45% | -$15.6K |
|
3747
Cyclerion Therapeutics
CYCN
$16.7M
| $20.8K | ﹤0.01% |
+91
| New | +$25.8K |
|
3748
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $20.8K | ﹤0.01% |
1,537
-1,148
| -43% | -$17.8K |
|
|
ZEUS
3749
DELISTED
Olympic Steel
ZEUS
| $20.8K | ﹤0.01% |
1,523
-428
| -22% | -$6.36K |
|
|
ASNA
3750
DELISTED
Ascena Retail Group, Inc.
ASNA
| $20.7K | ﹤0.01% |
1,697
-1,265
| -43% | -$26.8K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2019 Portfolio in Review
As of Q2 2019, BNP Paribas Financial Markets held 4,663 positions worth $50.2B, up 8.5% from $46.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q2 2019 filing shows 353 new, 1,075 increased, 2,687 reduced and 125 closed positions. Its largest new stake was Cigna: 315,599 shares worth $49.7M. The largest sale was Invesco QQQ Trust, an estimated $995M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.6% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2019 buy was Cigna: 315,599 shares worth $49.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $478M increase.
- BNP Paribas Financial Markets's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $995M.
- BNP Paribas Financial Markets fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $40.4M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $50.2B portfolio in Q2 2019.
- BNP Paribas Financial Markets opened 353 new positions and closed 125 in Q2 2019.
- BNP Paribas Financial Markets's portfolio value rose 8.5% quarter-over-quarter to $50.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.